Clinical Trial: Evaluating the Effect of Inhaled Technosphere Insulin Vs Rapid Acting Analogue Insulin on Exercise-Induced Hypoglycemia in Adults with Type 1 Diabetes Using Automated Insulin Delivery

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06880835) titled 'Evaluating the Effect of Inhaled Technosphere Insulin Vs Rapid Acting Analogue Insulin on Exercise-Induced Hypoglycemia in Adults with Type 1 Diabetes Using Automated Insulin Delivery' on March 12.

Brief Summary: This investigator-initiated study will enroll about 30 adults 18 to 60 years of age with type 1 diabetes (T1D) who are using the Tandem t:slim X2 insulin pump with Control-IQ technology (Control-IQ). The study is being done to find out if inhaled insulin given for a meal is safer and better to use than a bolus of insulin through your pump when you exercise following a meal. Participants are asked to complete three study ex...